Braveheart’s Stock Increases by 14% After Securing CEO’s Stake in IQ-AI

2 min read | October 11, 2024 09:53 PM AEDT | By Team Kalkine Media

Highlights

  1. Braveheart Investment Group has acquired a 29.5% stake in IQ-AI, a brain cancer diagnostics company, from CEO Trevor Brown.

  2. The transaction is classified as a related party transfer, with shares purchased at a price of 1.1 pence each.

  3. Following the announcement, shares of both Braveheart and IQ-AI experienced an increase of over 14%.

Overview

Braveheart Investment Group PLC {LSE:BRH} has announced the acquisition of a 29.5% stake in brain cancer diagnostics firm IQ-AI through a transaction involving chief executive Trevor Brown. This acquisition, valued at approximately £719,000, has been classified as a related party transfer due to Brown's leadership role in both organizations.

In this transaction, Brown transferred 65,415,862 shares of IQ-AI to Braveheart at a price of 1.1 pence per share, amounting to £503,371. Additionally, a further 19,654,779 shares were acquired from a company owned by Brown’s children under the same terms.

Braveheart's independent directors noted the opportunity to acquire a substantial stake in IQ-AI at what was perceived as an attractive entry price. In a statement, the company highlighted that the directors acknowledged progress being made by IB, a subsidiary of IQ-AI, in its Phase 1 Clinical Trial of gallium maltolate, which is aimed at treating brain cancer.

The acquisition aligns with Braveheart's strategic focus on sectors that demonstrate potential for growth and innovation. The directors expressed optimism about the synergies between Braveheart and IQ-AI, emphasizing that the IQ-AI business complements Braveheart's strategic goals.

Following the announcement of this acquisition, shares in both Braveheart and IQ-AI surged, rising by more than 14%. Braveheart's shares reached 4 pence, while IQ-AI's shares increased to 1.38 pence, reflecting positive market sentiment surrounding the transaction. This development signifies an important step in Braveheart's strategy to enhance its portfolio with companies in the healthcare sector, particularly those focused on innovative diagnostic solutions.

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.